Orchestra BioMed
OBIO
OBIO
42 hedge funds and large institutions have $114M invested in Orchestra BioMed in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 5 reducing their positions, and 5 closing their positions.
Holders
42
Holders Change
+3
Holders Change %
+7.69%
% of All Funds
0.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
23
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$10.9M |
2 |
2
BlackRock
New York
|
$11.6M |
3 |
PA
3
Perceptive Advisors
New York
|
$21.2M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$3.63M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$1.26M |